I agree with you I think it is the past abuse of the reverse split that has got FINRA's attention. FINRA has been cracking down on other penny stocks I own due to toxic financing deals and reverse splits. IMO if they do get the reverse split approved then it may be there last one for 2012 even though they have voted to have up to two more in 2012. Either way I think this stock will be very volatile in 2012.
As far as Tesetaxel goes I think most agree this will be a blockbuster drug. We should be getting news on the phase II for gastric cancer possibly at the OneMedForum Conference on January 11th 2012. I also think we will be getting news on the start of phase III in gastric cancer and SPA approval from the FDA soon. Good Luck to you as well. I too have been in and out of GNTA since 2008. I have lost money and have gained money on this stock as well. The hardest part of investing in this company is knowing when to buy due to all the toxic financing and reverse splits.
News 
Market Data 
Discover 
